Work

Misidentification of Candida duobushaemulonii associated to superficial infection and reduced susceptibility to azoles

Year: 2019
Type: conference-paper
Abstract: Objectives: Candidiasis by Candida haemulonii complex (Candida haemulonii and Candida duobushaemulonii) and closely related species, such as Candida auris and Candida pseudohaemulonii that show reduced susceptibility to antifungal drugs are increasing. Conventional phenotypic diagnostic methods are unable to identify these species. Therefore, their prevalence may have been underestimated. The aim was to use novel molecular techniques to identify isolates from a stock culture collection with dubious identities, which could belong to emerging and multi-resistant species related to C. haemulonii.Methods: The study included 150 clinical isolates from the yeast stock collection of the Medical Mycology Laboratory at the University of the Basque Country (UPV/EHU) collected between 1993 and 2017 that could be inaccurately identified by API® ID 32C (bioMérieux, France). Three clinical confirmed isolates (two C. auris and one C. duobushaemulonii) and one C. pseudohaemulonii reference strain (CBS 10004) were included as positive controls. All isolates were analysed by two different PCR techniques: a C. auris-specific PCR1 and a C. haemulonii complex-tetraplex PCR2 . Species identities were confirmed by sequencing the ITS1-5.8S-ITS2 region. Finally, in vitro susceptibility to nine antifungal agents (anidulafungin, micafungin, caspofungin, posaconazole, voriconazole, itraconazole, fluconazole, amphotericin B and 5-fluorocytosine) was tested using SensititreTM YeastOneYO10 (Thermo Scientific, USA).Results: C. auris-specific PCR accurately identified both confirmed isolates of C. auris and no bands were detected for the other isolates. Eight isolates previously identified as C. haemulonii were confirmed by tetraplex PCR. Neither C. auris nor C. pseudohaemulonii were detected in the collection.One isolate from a toenail previously identified in 1996 by API® ID 32C panel as Candida intermedia produced a 115 bp sized band in the tetraplex PCR, corresponding to C. duobushaemulonii. All identifications were confirmed by ITS sequencing. The C. duobushaemulonii isolate was re-analysed by the current API®ID 32C panel, which identified it as Candida sake. The C. duobushaemulonii isolate was susceptible dose-dependent to itraconazole (MIC 0.5 µg/mL) and fluconazole (MIC 32 µg/mL).All C. haemulonii were susceptible dose-dependent to itraconazole (MIC 0.5 µg/mL) and fluconazole (MIC 16 µg/mL) except two, who were resistant (MIC 1 and 64 µg/mL, respectively), and their susceptibility to amphotericin B was reduced (MIC 2->8 µg/mL). The C. pseudohaemulonii reference strain CBS 10004 was susceptible to all antifungal drugs. Both C. auris isolates showed resistance to fluconazole (MIC >256 µg/mL), dose-dependent susceptibility to itraconazole (MIC 0.25 µg/mL), and one of them was also susceptible dose-dependent to voriconazole (MIC 2 µg/mL).Conclusion: Candida haemulonii complex and closely related species may have been associated to superficial infections prior to its emergence related to invasive infections, as indicated by the identification of a C. duobushaemulonii isolate from before 2012, when current classification of the complex was established. This complex shows reduced susceptibility to azoles and amphotericin B.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7197304311
FWCI:
Cites:
Cited by:
Related to: 10